Senior insider sale
President and Chairman at Y-MABS THERAPEUTICS, INC. — senior position signals high conviction
$64.1K
3.90K shares
What this filing means
GAD THOMAS plans to sell 3.90K shares of Y-MABS THERAPEUTICS, INC. valued at approximately $64.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/5/2024ACC: 0001964306-24-000142
DirectorOfficer· President and Chairman
Since Sep 2018
3.90K
Shares to sell
$64.1K
Approx. market value
3.90K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
1/17/2024
3.90KTotal acquired3.90K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/17/2024 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 3.90K | — |
| Total | 3.90K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.90K
Market value
$64.1K
3/5/2024
Total
Units
3.90K
Value
$64.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/5/2024 | 3.90K | $64.1K | NASDAQ | Planned |
| Total | 3.90K | $64.1K | ||